Accessibility Menu
Lensar Stock Quote

Lensar (NASDAQ: LNSR)

$10.60
(-7.3%)
-0.84
Price as of November 7, 2025, 4:00 p.m. ET

KEY DATA POINTS

Current Price
$10.60
Daily Change
(-7.3%) $0.84
Day's Range
$10.53 - $11.54
Previous Close
$10.60
Open
$11.44
Beta
0.53
Volume
164,809
Average Volume
58,460
Market Cap
126.5M
Market Cap / Employee
$10.60M
52wk Range
$6.52 - $17.31
Revenue
-
Gross Margin
0.45%
Dividend Yield
N/A
EPS
-$4.39
CAPs Rating
-
Industry
Healthcare Equipment and Supplies

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Lensar Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
LNSR+54.29%+28.95%+5.21%+18%
S&P+12.65%+91.73%+13.89%+101%

Lensar Company Info

LENSAR, Inc. engages in the development of femtosecond laser technology for refractive cataract surgery. Its product offers automation and customization options for astigmatism treatment planning and other steps of the refractive cataract surgery procedure. The company was founded by Scott Addyman, Randy W. Frey, and Ronald R. Krueger in 2004 and is headquartered in Orlando, FL.

News & Analysis

Financial Health

General

Q3 2025YOY Change
Revenue$14.32M5.7%
Gross Profit$5.81M-3.8%
Gross Margin40.56%-4.0%
Market Cap$147.39M177.2%
Market Cap / Employee$1.05M0.0%
Employees1407.7%
Net Income-$3.71M-147.2%
EBITDA-$6.42M-2587.4%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q3 2025YOY Change
Net Cash$7.64M-26.9%
Accounts Receivable$6.19M16.4%
Inventory20.638.3%

Liabilities

Q3 2025YOY Change
Long Term Debt$2.19M65.8%
Short Term Debt$0.69M20.7%

Ratios

Q3 2025YOY Change
Return On Assets-77.94%-52.9%
Return On Invested Capital-57.57%-19.2%

Cash Flow

Q2 2025YOY Change
Free Cash Flow-$5.08M-30.4%
Operating Free Cash Flow-$5.00M-32.3%

Valuation

MetricQ4 2024Q1 2025Q2 2025Q3 2025YoY Change
Price to Book4.5733.84-7.01-6.39-373.33%
Price to Sales1.942.912.692.52131.26%
Price to Tangible Book Value6.33-131.64-5.54-5.13-258.28%
Enterprise Value to EBITDA-532.05-33.36-29.46-23.13-89.11%
Return on Equity-95.4%-304.1%-350.2%-422.3%1000.46%
Total Debt$2.61M$2.47M$2.33M$2.88M52.14%

No results found

No podcast episodes available.

No results found

No transcripts available.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.